revakinagene taroretcel-lwey (Encelto)

Indications

• treatment of macular telangiectasia type 2

Mechanism of action

• encapsulated cell therapy designed to continually deliver therapeutic doses of ciliary neurotrophic factor (CNTF) to the retina
  • consists of a surgically implanted small semi-permeable capsule containing allogeneic retinal pigment epithelium cells genetically engineered to produce CNTF

More general terms

• gene therapy
• implant